| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |